Skip to content

Anesthetic Management of Diabetes in Perioperative Urology and Visceral Surgery

Anesthetic Management of Diabetes in Perioperative Urology and Visceral Surgery: Adherence to a New Protocol at Brest CHU

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06553170
Acronym
DIAPRO-BREST
Enrollment
196
Registered
2024-08-14
Start date
2017-12-01
Completion date
2019-09-01
Last updated
2024-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Keywords

diabetes, glycemic balance, anesthesia, perioperative medecine

Brief summary

It is recognized that a poor glycemic, pre- and intraoperative balance is the source of increase in morbimortality. There was no local protocol at the CHRU Brest regarding the perioperative management of the diabetic patient. This retrospective observational work aims to assess the application of the French recommendations for the perioperative management of diabetes, and compare management before and after the introduction of a protocol based on its recommendations published in 2017 by the SFAR. The main endpoint is the percentage of patients for whom half of the patients recommendations from the local protocol were implemented for each of the recommendations evaluated and applicable to each patient, before and after protocol and staff training.

Detailed description

Half of the recommandations are implemented for each recommendation evaluated applicable in 29% of patients(n=25) in the before group versus 66.23% (n=52) in the after group (p\<0.05). This corresponds to an improvement significant of 36.23% for our primary endpoint.

Interventions

None listed

Sponsors

University Hospital, Brest
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL

Inclusion criteria

* patients diabetics * urology or visceral surgery

Exclusion criteria

* ambulatory surgery

Design outcomes

Primary

MeasureTime frameDescription
follow the recommendations1 year afterThe main endpoint is the percentage of patients for whom half of patients recommendations of the local protocol were implemented for each of the recommendations evaluated and applicable to each patient, before and after the application of the protocol and training staff.

Secondary

MeasureTime frameDescription
complications and mortality1 year afterSecondary endpoints are hospital mortality, the occurrence of early postoperative complications related to diabetes, the occurrence of complications post-operative surgery, and finally the occurrence of medical complications not related to Diabetes.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026